"Designing Growth Strategies is in our DNA"

Short Bowel Syndrome Market Size, Share & Industry Analysis, By Type (GLP-2, Growth Hormone, and Glutamine), By Distribution Channel (Hospital Pharmacies and Online & Retail Pharmacies), and Regional Forecast, 2026-2034

Last Updated: January 19, 2026 | Format: PDF | Report ID: FBI107071

 

We will customize the report to meet your research goals, helping you gain a competitive edge, and make informed decisions.

  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
    4. Market Trends
  4. Key Insights
    1. Prevalence of Short Bowel Syndrome, By Key Countries, 2025
    2. Key Industry Developments - Mergers, Acquisitions, Partnerships, etc.
    3. Impact of COVID-19 on the Global Market 
  5. Global Short Bowel Syndrome Market Analysis, Insights and Forecast, 2021-2034
    1. Market Analysis, Insights and Forecast – By Type
      1. GLP-2
      2. Growth Hormone
      3. Glutamine
    2. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Online & Retail Pharmacies
    3. Market Analysis, Insights and Forecast – By Region
      1. North America
      2. Europe
      3. Asia Pacific
      4. Latin America
      5. Middle East & Africa
  6. North America Short Bowel Syndrome Market Analysis, Insights and Forecast, 2021-2034
    1. Market Analysis, Insights and Forecast – By Type
      1. GLP-2
      2. Growth Hormone
      3. Glutamine
    2. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Online & Retail Pharmacies
    3. Market Analysis, Insights and Forecast – By Country
      1. U.S.
      2. Canada
  7. Europe Short Bowel Syndrome Market Analysis, Insights and Forecast, 2021-2034
    1. Market Analysis, Insights and Forecast – By Type
      1. GLP-2
      2. Growth Hormone
      3. Glutamine
    2. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Online & Retail Pharmacies
    3. Market Analysis, Insights and Forecast – By Country/Sub-region
      1. U.K.
      2. Germany
      3. France
      4. Spain
      5. Italy
      6. Rest of Europe
  8. Asia Pacific Short Bowel Syndrome Market Analysis, Insights and Forecast, 2021-2034
    1. Market Analysis, Insights and Forecast – By Type
      1. GLP-2
      2. Growth Hormone
      3. Glutamine
    2. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Online & Retail Pharmacies
    3. Market Analysis, Insights and Forecast – By Country/Sub-region
      1. Japan
      2. South Korea
      3. Australia
      4. China
      5. India
      6. Southeast Asia
      7. Rest of Asia Pacific
  9. Latin America Short Bowel Syndrome Market Analysis, Insights and Forecast, 2021-2034
    1. Market Analysis, Insights and Forecast – By Type
      1. GLP-2
      2. Growth Hormone
      3. Glutamine
    2. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Online & Retail Pharmacies
    3. Market Analysis, Insights and Forecast – By Country/Sub-region
      1. Brazil
      2. Mexico
      3. Argentina
      4. Colombia
      5. Rest of Latin America
  10. Middle East & Africa Short Bowel Syndrome Market Analysis, Insights and Forecast, 2021-2034
    1. Market Analysis, Insights and Forecast – By Type
      1. GLP-2
      2. Growth Hormone
      3. Glutamine
    2. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Online & Retail Pharmacies
    3. Market Analysis, Insights and Forecast – By Country/Sub-region
      1. Turkey
      2. Saudi Arabia
      3. UAE
      4. Rest of Middle East & Africa
  11. Competitive Analysis
    1. Global Market Share Analysis (2025)
    2. Company Profiles
      1. Takeda Pharmaceutical Company Limited
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      2. Merck KGaA
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      3. ZEALAND PHARMA
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      4. Ironwood
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      5. Hanmi Pharm. Co., Ltd.
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      6. Nestlé
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      7. Jaguar Health
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      8. EnteraBio Ltd.
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      9. OxThera
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
    4. Market Trends
  4. Key Insights
    1. Prevalence of Short Bowel Syndrome, By Key Countries, 2025
    2. Key Industry Developments - Mergers, Acquisitions, Partnerships, etc.
    3. Impact of COVID-19 on the Global Market 
  5. Global Short Bowel Syndrome Market Analysis, Insights and Forecast, 2021-2034
    1. Market Analysis, Insights and Forecast – By Type
      1. GLP-2
      2. Growth Hormone
      3. Glutamine
    2. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Online & Retail Pharmacies
    3. Market Analysis, Insights and Forecast – By Region
      1. North America
      2. Europe
      3. Asia Pacific
      4. Latin America
      5. Middle East & Africa
  6. North America Short Bowel Syndrome Market Analysis, Insights and Forecast, 2021-2034
    1. Market Analysis, Insights and Forecast – By Type
      1. GLP-2
      2. Growth Hormone
      3. Glutamine
    2. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Online & Retail Pharmacies
    3. Market Analysis, Insights and Forecast – By Country
      1. U.S.
      2. Canada
  7. Europe Short Bowel Syndrome Market Analysis, Insights and Forecast, 2021-2034
    1. Market Analysis, Insights and Forecast – By Type
      1. GLP-2
      2. Growth Hormone
      3. Glutamine
    2. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Online & Retail Pharmacies
    3. Market Analysis, Insights and Forecast – By Country/Sub-region
      1. U.K.
      2. Germany
      3. France
      4. Spain
      5. Italy
      6. Rest of Europe
  8. Asia Pacific Short Bowel Syndrome Market Analysis, Insights and Forecast, 2021-2034
    1. Market Analysis, Insights and Forecast – By Type
      1. GLP-2
      2. Growth Hormone
      3. Glutamine
    2. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Online & Retail Pharmacies
    3. Market Analysis, Insights and Forecast – By Country/Sub-region
      1. Japan
      2. South Korea
      3. Australia
      4. China
      5. India
      6. Southeast Asia
      7. Rest of Asia Pacific
  9. Latin America Short Bowel Syndrome Market Analysis, Insights and Forecast, 2021-2034
    1. Market Analysis, Insights and Forecast – By Type
      1. GLP-2
      2. Growth Hormone
      3. Glutamine
    2. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Online & Retail Pharmacies
    3. Market Analysis, Insights and Forecast – By Country/Sub-region
      1. Brazil
      2. Mexico
      3. Argentina
      4. Colombia
      5. Rest of Latin America
  10. Middle East & Africa Short Bowel Syndrome Market Analysis, Insights and Forecast, 2021-2034
    1. Market Analysis, Insights and Forecast – By Type
      1. GLP-2
      2. Growth Hormone
      3. Glutamine
    2. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Online & Retail Pharmacies
    3. Market Analysis, Insights and Forecast – By Country/Sub-region
      1. Turkey
      2. Saudi Arabia
      3. UAE
      4. Rest of Middle East & Africa
  11. Competitive Analysis
    1. Global Market Share Analysis (2025)
    2. Company Profiles
      1. Takeda Pharmaceutical Company Limited
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      2. Merck KGaA
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      3. ZEALAND PHARMA
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      4. Ironwood
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      5. Hanmi Pharm. Co., Ltd.
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      6. Nestlé
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      7. Jaguar Health
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      8. EnteraBio Ltd.
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      9. OxThera
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
Read Less

Figure 1: Global Short Bowel Syndrome Market Revenue Breakdown (USD billion, %) by Region, 2025 & 2034

Figure 2: Global Short Bowel Syndrome Market Value Share (%), by Type, 2025 & 2034

Figure 3: Global Short Bowel Syndrome Market Value Share (%), by Distribution Channel, 2025 & 2034

Figure 4: Global Short Bowel Syndrome Market Value Share (%), by Region, 2025 & 2034

Figure 5: North America Short Bowel Syndrome Market Value (USD billion), by Type, 2025 & 2034

Figure 6: North America Short Bowel Syndrome Market Value Share (%), by Type, 2025

Figure 7: North America Short Bowel Syndrome Market Value (USD billion), by Distribution Channel, 2025 & 2034

Figure 8: North America Short Bowel Syndrome Market Value Share (%), by Distribution Channel, 2025

Figure 9: North America Short Bowel Syndrome Market Value (USD billion), By Country, 2025 & 2034

Figure 10: North America Short Bowel Syndrome Market Value Share (%), By Country, 2025

Figure 11: Europe Short Bowel Syndrome Market Value (USD billion), by Type, 2025 & 2034

Figure 12: Europe Short Bowel Syndrome Market Value Share (%), by Type, 2025

Figure 13: Europe Short Bowel Syndrome Market Value (USD billion), by Distribution Channel, 2025 & 2034

Figure 14: Europe Short Bowel Syndrome Market Value Share (%), by Distribution Channel, 2025

Figure 15: Europe Short Bowel Syndrome Market Value (USD billion), By Country/ Sub-region, 2025 & 2034

Figure 16: Europe Short Bowel Syndrome Market Value Share (%), By Country/ Sub-region, 2025

Figure 17: Asia Pacific Short Bowel Syndrome Market Value (USD billion), by Type, 2025 & 2034

Figure 18: Asia Pacific Short Bowel Syndrome Market Value Share (%), by Type, 2025

Figure 19: Asia Pacific Short Bowel Syndrome Market Value (USD billion), by Distribution Channel, 2025 & 2034

Figure 20: Asia Pacific Short Bowel Syndrome Market Value Share (%), by Distribution Channel, 2025

Figure 21: Asia Pacific Short Bowel Syndrome Market Value (USD billion), By Country/ Sub-region, 2025 & 2034

Figure 22: Asia Pacific Short Bowel Syndrome Market Value Share (%), By Country/ Sub-region, 2025

Figure 23: Latin America Short Bowel Syndrome Market Value (USD billion), by Type, 2025 & 2034

Figure 24: Latin America Short Bowel Syndrome Market Value Share (%), by Type, 2025

Figure 25: Latin America Short Bowel Syndrome Market Value (USD billion), by Distribution Channel, 2025 & 2034

Figure 26: Latin America Short Bowel Syndrome Market Value Share (%), by Distribution Channel, 2025

Figure 27: Latin America Short Bowel Syndrome Market Value (USD billion), By Country/ Sub-region, 2025 & 2034

Figure 28: Latin America Short Bowel Syndrome Market Value Share (%), By Country/ Sub-region, 2025

Figure 29: Middle East & Africa Short Bowel Syndrome Market Value (USD billion), by Type, 2025 & 2034

Figure 30: Middle East & Africa Short Bowel Syndrome Market Value Share (%), by Type, 2025

Figure 31: Middle East & Africa Short Bowel Syndrome Market Value (USD billion), by Distribution Channel, 2025 & 2034

Figure 32: Middle East & Africa Short Bowel Syndrome Market Value Share (%), by Distribution Channel, 2025

Figure 33: Middle East & Africa Short Bowel Syndrome Market Value (USD billion), By Country/ Sub-region, 2025 & 2034

Figure 34: Middle East & Africa Short Bowel Syndrome Market Value Share (%), By Country/ Sub-region, 2025

Figure 35: Global Short Bowel Syndrome Market Share (%), By Company, 2025

Table 1: Global Short Bowel Syndrome Market Revenue (USD billion) Forecast, by Type, 2021–2034

Table 2: Global Short Bowel Syndrome Market Revenue (USD billion) Forecast, by Distribution Channel, 2021–2034

Table 3: Global Short Bowel Syndrome Market Revenue (USD billion) Forecast, by Region, 2021–2034

Table 4: North America Short Bowel Syndrome Market Revenue (USD billion) Forecast, by Type, 2021–2034

Table 5: North America Short Bowel Syndrome Market Revenue (USD billion) Forecast, by Distribution Channel, 2021–2034

Table 6: North America Short Bowel Syndrome Market Revenue (USD billion) Forecast, By Country, 2021–2034

Table 7: Europe Short Bowel Syndrome Market Revenue (USD billion) Forecast, by Type, 2021–2034

Table 8: Europe Short Bowel Syndrome Market Revenue (USD billion) Forecast, by Distribution Channel, 2021–2034

Table 9: Europe Short Bowel Syndrome Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021–2034

Table 10: Asia Pacific Short Bowel Syndrome Market Revenue (USD billion) Forecast, by Type, 2021–2034

Table 11: Asia Pacific Short Bowel Syndrome Market Revenue (USD billion) Forecast, by Distribution Channel, 2021–2034

Table 12: Asia Pacific Short Bowel Syndrome Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021–2034

Table 13: Latin America Short Bowel Syndrome Market Revenue (USD billion) Forecast, by Type, 2021–2034

Table 14: Latin America Short Bowel Syndrome Market Revenue (USD billion) Forecast, by Distribution Channel, 2021–2034

Table 15: Latin America Short Bowel Syndrome Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021–2034

Table 16: Middle East & Africa Short Bowel Syndrome Market Revenue (USD billion) Forecast, by Type, 2021–2034

Table 17: Middle East & Africa Short Bowel Syndrome Market Revenue (USD billion) Forecast, by Distribution Channel, 2021–2034

Table 18: Middle East & Africa Short Bowel Syndrome Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021–2034

Short Bowel Syndrome Market
  • 2021-2034
  • 2025
  • 2021-2024
  • 127
Download Free Sample

    man icon
    Mail icon
    Captcha refresh
Growth Advisory Services
    How can we help you uncover new opportunities and scale faster?
Clients
3M
Toshiba
Fresenius
Johnson
Siemens
Abbot
Allergan
American Medical Association
Becton, Dickinson and Company
Bristol-Myers Squibb Company
Henry Schein
Mckesson
Mindray
National Institutes of Health (NIH)
Nihon Kohden
Olympus
Quest Diagnostics
Sanofi
Smith & Nephew
Straumann

Related Reports